Aura Biosciences Inc Financial Flexibility Index
Aura Biosciences Inc financial flexibility index. Aura Biosciences Inc (AURA) has a Financial Flexibility Index of -0.98x as of March 2026. Free cash flow of $-29.79 Million (operating CF $-29.89 Million minus capex $102.00K) represents -1% of total liabilities ($30.43 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Aura Biosciences Inc (2019–2025)
Financial flexibility index of Aura Biosciences Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Aura Biosciences Inc across 7 annual periods. Explore debt repayment capacity of Aura Biosciences Inc to assess how comfortably operating cash covers total debt obligations.
Aura Biosciences Inc Financial Flexibility Index by Year (2019–2025)
Aura Biosciences Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Aura Biosciences Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Aura Biosciences Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.59x | $-84.30 Million | $-84.74 Million | $32.52 Million | ▼ -0.8% |
| 2024 | -2.57x | $-78.55 Million | $-79.81 Million | $30.53 Million | ▼ -19.1% |
| 2023 | -2.16x | $-63.14 Million | $-63.85 Million | $29.23 Million | ▼ -14.5% |
| 2022 | -1.89x | $-53.51 Million | $-54.60 Million | $28.35 Million | ▲ +51.9% |
| 2021 | -3.93x | $-30.29 Million | $-32.41 Million | $7.71 Million | ▲ +54.3% |
| 2020 | -8.59x | $-23.55 Million | $-24.32 Million | $2.74 Million | ▼ -193.1% |
| 2019 | -2.93x | $-18.45 Million | $-20.67 Million | $6.29 Million | — |